The Plastic Surgeon's Verdict: Gender Surgery Is Mutilation, Not Medicine - Dr.Patrick Lappert (#30)
18 August 2025
With Dr Patrick Lappert
Global
The Cass Review concluded that the evidence base for paediatric gender medicine is remarkably weak. Dr Patrick Lappert, a US reconstructive surgeon with more than forty years of clinical experience, arrives at the same conclusion from inside the operating theatre. He argues that gender surgeries are cosmetic procedures performed on patients with a psychiatric condition — something his specialty's ethics explicitly prohibit — and that the entire field rests on Level 5 evidence: expert opinion alone. His testimony bears directly on questions NHS England and UK courts continue to work through.
Dr Patrick Lappert spent his career as a plastic and reconstructive surgeon, training first in general surgery before the US Navy sent him for specialist reconstructive training. Over more than four decades he treated trauma patients and performed the restorative work reconstructive surgery was designed for. He has since testified in state and federal proceedings concerning gender surgeries, and his clinical vantage point gives his assessment unusual authority. He is not a campaigner or an outside commentator but a practitioner describing what his specialty has become and why he believes it has lost its ethical bearings. His central argument is one the surgical profession has not openly confronted. Plastic surgeons operate under a clear ethical prohibition against performing cosmetic procedures on patients whose dissatisfaction with their body is driven by body dysmorphic disorder. Lappert contends that gender dysphoria, as it presents in patients referred for surgical intervention, falls within that diagnostic category. Operating anyway — producing anatomical changes that cannot be reversed — is not medicine in his account. It is a failure of clinical duty dressed in the language of affirmation. He does not avoid clinical detail. Phalloplasty, he explains, produces what he describes as a non-functional artifact rather than a working organ. Vaginoplasty carries risks of serious complications. Chest masculinisation in young female patients permanently severs the nerve pathway linked to the physiological bonding response between a mother and nursing infant. He references documented surgical outcomes including those experienced by Jazz Jennings, and cites Swedish data pointing to markedly elevated rates of poor mental health outcomes following transition. In his reading, these are not remote risks but predictable consequences of an approach that has never been adequately evidenced. On evidence, Lappert is unsparing. He describes gender surgery as operating on Level 5 evidence — expert opinion, the lowest rung of the evidence hierarchy — while presenting itself as established standard of care. This mirrors the central finding of the Cass Review, which examined the evidence base for paediatric gender medicine in England and found it to be of poor quality and insufficient to support the clinical practices that had become routine. NHS England subsequently restricted puberty blockers and cross-sex hormones for under-eighteens, and the question of surgical provision for younger adults remains live in UK policy discussions. Informed consent runs through the conversation as a persistent concern. Lappert argues that patients — particularly younger patients — cannot adequately grasp the permanent consequences of these interventions before agreeing to them. That question has direct resonance in a UK context. Legal proceedings in England examining consent to gender-related medical treatment have turned on whether children and adolescents can give valid agreement to procedures whose long-term effects are not well established. The same consent questions now apply across the broader landscape of gender-related clinical practice as NHS services are restructured. What gives the episode its particular weight is Lappert's location inside the profession. As UK institutions work through the Cass Review's implementation, revised NHS commissioning guidelines, and ongoing parliamentary scrutiny of gender services, independent surgical testimony of this kind forms part of the evidential record that future policy will need to address.
